TuisEYPT • NASDAQ
add
Eyepoint Pharmaceuticals Inc
Vorige sluiting
$6,54
Dagwisseling
$6,06 - $6,60
Jaarwisseling
$3,91 - $21,26
Markkapitalisasie
437,80 m USD
Gemiddelde volume
839,11 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 11,59 m | -17,39% |
Bedryfskoste | 125,32 m | 77,58% |
Netto inkomste | -41,40 m | -193,63% |
Netto winsgrens | -357,26 | -255,45% |
Wins per aandeel | -0,64 | -93,94% |
EBITDA | -44,77 m | -175,66% |
Effektiewe belastingkoers | -0,22% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 370,91 m | 12,04% |
Totale bates | 418,46 m | 17,82% |
Totale aanspreeklikheid | 81,96 m | -7,76% |
Totale ekwiteit | 336,50 m | — |
Uitstaande aandele | 68,73 m | — |
Prys om te bespreek | 1,33 | — |
Opbrengs op bates | -31,44% | — |
Opbrengs op kapitaal | -37,61% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -41,40 m | -193,63% |
Kontant van bedrywe | -35,85 m | -55,13% |
Kontant van beleggings | -95,96 m | -103,53% |
Kontant van finansiering | 151,68 m | -30,57% |
Netto kontantverandering | 19,87 m | -86,59% |
Beskikbare kontantvloei | -17,74 m | -148,52% |
Meer oor
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
Gestig
1987
Webwerf
Werknemers
165
